Research focus
About the research
What are the molecular underpinnings of epithelial cancers, particularly triple-negative breast cancer?
Read the full research overview
Jennifer Pietenpol is Professor of Biochemistry and Ingram Professor of Cancer Research. The laboratory focuses on uncovering the molecular underpinnings of epithelial cancers, with particular emphasis on triple-negative breast cancer and the signaling pathways controlled by the p53 family of tumor-suppressor proteins. The laboratory generated the first robust molecular classification of triple-negative breast cancer, identifying basal-like, mesenchymal and luminal androgen receptor subtypes. Current research includes expanding molecular subtyping of triple-negative breast cancer to build a comprehensive breast cancer transcriptomic atlas.
Selected publications
3 listedMulti-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes
Nature Communications
Acquisition of aneuploidy drives mutant p53-associated gain-of-function phenotypes
Nature Communications
Atezolizumab in Combination With Carboplatin and Survival Outcomes in Patients With Metastatic Triple-Negative Breast Cancer: The TBCRC 043 Phase 2 Randomized Clinical Trial
JAMA Oncology
People & alumni
Team details haven’t been added. See the lab’s website for its current members.
Alumni details haven’t been added. Check the lab’s official website.
Sources & listing information
Find Research Labs maintains this page using public sources. The faculty member, lab, and university have not claimed or approved this listing. Listing a lab does not indicate endorsement, partnership, or a recruiting opportunity.
Request a correction or removal ↗ · About directory listings